Drug Trial Radar · NCT03915431
A Study of NCS-01 in Patients With Acute Ischemic Stroke
Last checked: Nov 19, 2026Latest source record: Sep 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
16
Planned (sponsor's estimate)
Start
Feb 27, 2020
Primary completion
Oct 2027
Study completion Oct 2028
Sponsor
- Lead sponsor
- NC Medial Research IncIndustry
- Sponsor type
- Industry
- First posted
- Apr 16, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
Conditions
- Ischemic Stroke
Interventions
NCS-01Biological
single infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with adverse events -Safety by Incidence of Treatment-Emergent Adverse EventsTime frame: multiple times for the duration of the study (baseline through Month 12)
- National Institutes of Health Stroke Scale (NIHSS)Time frame: 1 hour, 3 hours, and 6 hours post infusion
- Number of participants with change in in physical examinationTime frame: multiple times from baseline through Month 12
- Number of participants with change in Electrocardiography (ECG)Time frame: multiple times for the duration of the study (baseline through Month 12)
- Number of participants with change in clinical laboratory evaluationsTime frame: multiple times for the duration of the study (baseline through Month 12)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Miami
Miami, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.